Loading...
Loading...
Nomura reiterated its Buy rating on Cognizant Technology Solutions
CTSH and increased its price target from $75 to $80.
Nomura noted, “We liked the CTSH 3Q results on two counts: 1) diversified growth with outperformance vs. peers across all geographies; and 2) better-than anticipated performance in Retail/manufacturing and BFSI offsetting the sluggish growth in healthcare (25% of revenues). We expect market share gains in BFSI, continued traction in retail/manufacturing and the diversified service line portfolio to counter possible growth moderation in the pharma portion of healthcare in FY13F. Our expectations remain intact, and we see CTSH growing revenues and EPS at CAGR of ~18% over FY11-14F. Our earnings estimates are in line with consensus; we believe street pessimism on valuation multiples will fade as Cognizant continues to outperform peers."
Cognizant Technology Solutions closed at $65.27 on Thursday.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in